{{Rsnum
|rsid=193929380
|Chromosome=11
|Orientation=minus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=INS
|position=2160901
|Gene_s=INS,SIT1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Status=Merged
|Merged=80356663
}}{{ClinVar
|rsid=193929380
|Reversed=1
|FwdREF=C
|FwdALT=A
|REF=G
|ALT=T
|RSPOS=2182131
|CHROM=11
|dbSNPBuildID=136
|SSR=0
|SAO=0
|VP=050168000a11000002110100
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000011.9:g.2182131G>T
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=0
|CLNSRCID=176730.0012
|CLNSIG=5
|CLNCUI=C1833104
|CLNDBN=Permanent neonatal diabetes mellitus
|Disease=Permanent neonatal diabetes mellitus
|CLNACC=SCV000034569.1
|Tags=RV;PM;PMC;SLO;NSM;REF;OTH;OTHERKG;LSD;OM
}}{{PMID Auto
|PMID=17047922
|Title=Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.
}}

{{PMID Auto
|PMID=18171712
|Title=Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group.
}}